Saturday , April 21 2018
Home / health & Fitness / Private hospitals warned over surgeons

Private hospitals warned over surgeons

Drip with surgeons in background

Some of the failings that allowed rogue surgeon Ian Paterson to harm patients have been found to be widespread across private hospitals, inspectors say.

The Care Quality Commission said it was concerned about the "old-fashioned" approach to consultants which led to a lack of monitoring and checks.

The regulator said it meant there was a "real danger" poor practices were not being picked up or challenged.

Private hospitals said they were responding quickly to the findings.

The CQC looked at 206 private hospitals in what was the first comprehensive review of the sector.

These sites treat both private patients and those given NHS funding to be seen privately.

The CQC rated 70% as good or excellent.

'Exaggerated symptoms'

But it said there was a "significant concern" relating to governance and safety.

In particular, it highlighted the lack of proper checks and monitoring of senior doctors, mainly surgeons, to ensure they were only undertaking treatments they were qualified to do or carrying them out in a safe way.

It likened the failures to those found in the Paterson case, the breast surgeon who was found guilty of 17 counts of wounding with intent last year and sentenced to 20 years in jail.

He carried out botched operations on patients at private hospitals in the West Midlands.

The surgeon's trial heard he had wildly exaggerated his patients' cancer symptoms, leading them to have several needless operations which left them scarred for life physically and emotionally.

Image copyright SWNS
Image caption Breast surgeon Ian Paterson was found guilty of wounding with intent last year

Chief inspector of hospitals Prof Ted Baker described the approach to consultants as "old-fashioned" as it relied on informal systems and people knowing each other.

"Too often, safety was viewed as the responsibility of individual clinicians, rather than a corporate responsibility supported by formal governance processes.

"Where we found failings, we have been clear that improvements must be made, using our enforcement powers where needed to protect people."

Dr Howard Freeman, of the NHS Partners Network, which represents private providers, said providing safe and high-quality care was a "top priority".

He said where inspectors had highlighted problems hospitals were being "quick to respond".

The Royal College of Surgeons said there was "no room for complacency".

About admin

Our goal is to help you improve your life and improve your standard of living and gain more knowledge about what to do in all cases whether Business and Investing or Arts and Entertainment or

Check Also

Cystic fibrosis: Company urged to lower cost of life-changing drug

Image caption More than 10,000 people in the UK suffer from cystic fibrosis, which causes fatal lung damageA pharmaceutical company has been urged to drop the price of a life-changing cystic fibrosis drug for the NHS. Orkambi, which is made by Vertex Pharmaceuticals, is not available on the NHS and health ministers have called for an "urgent resolution". NHS England made a counter-offer to the initial deal but Vertex said that would not allow them to fund future medicines. Vertex said it wanted to reach an agreement "as soon as possible". Cystic fibrosis is a life-shortening genetic condition that causes fatal lung damage and affects around 10,400 people in the UK. Only around half of those with cystic fibrosis live to celebrate their 40th birthday. Orkambi is for people with the F508del mutation, which causes the production of an abnormal protein that disrupts how water and chloride are transported in the body. The drug has been shown in clinical trials to improve lung function..

Leave a Reply

Your email address will not be published. Required fields are marked *